https://www.openbell.ai/ 2026-10-16T15:55:11.208Z hourly 1.0 https://www.openbell.ai/support 2026-10-16T15:55:11.208Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-16T15:55:11.208Z monthly 0.5 https://www.openbell.ai/terms 2026-10-16T15:55:11.208Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-16T15:55:11.208Z hourly 0.8 https://www.openbell.ai/news/USB:1792166103974 2026-10-16T15:55:03.974Z daily 0.9 https://cdn.brandfetch.io/USB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evercore ISI Group Maintains Outperform on U.S. Bancorp, Raises Price Target to $67 Evercore ISI Group analyst Vijay Kumar has maintained an 'Outperform' rating on U.S. Bancorp (NYSE: USB) and increased the price target from $65 to $67. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/IBRX:1792165912582 2026-10-16T15:51:52.582Z daily 0.9 https://cdn.brandfetch.io/IBRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud ImmunityBio Announces Data From Its Phase 2/3 QUILT-3.032 Trial Of ANKTIVA In Combination With Bacillus Calmette-Guerin Demonstrates 71% Complete Response Rate In Participants With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer With Carcinoma In Situ ImmunityBio, Inc. announced long-term data from its Phase 2/3 QUILT-3.032 trial, revealing a 71% complete response rate for its treatment ANKTIVA in patients with BCG-unresponsive non-muscle invasive bladder cancer. The median duration of complete response was 26.6 months, with some responses lasting over 53 months. Additionally, the study reported an 84% cystectomy-free survival rate at 36 months and a 98.2% disease-specific survival rate at three years, with no severe treatment-related adverse events noted. https://www.openbell.ai/news/SPCX:1792165723000 2026-10-16T15:48:43.000Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Rocket-Launch-A-Spacex-Falcon-Heavy-Rock.jpg?width=250&height=187 SpaceX Q3 Earnings Countdown: 5 Debates to Watch SpaceX (NASDAQ: SPCX) is set to release its Q3 financial results on October 20, 2026, with an audio webcast scheduled for 4:30 p.m. ET. Analyst Kutgun Maral from Evercore ISI has raised his price target for the stock from $230 to $275, indicating an 85% upside potential. He anticipates a significant revenue increase, projecting annualized revenue to exceed $100 billion by the end of 2026, driven by strategic compute deals and growth in AI and connectivity sectors. As of the latest report, SpaceX's stock was down 1.81%, trading at $145.93. https://www.openbell.ai/news/WSE:1792165296404 2026-10-16T15:41:36.404Z daily 0.9 https://cdn.brandfetch.io/WSE/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Wise Group, Raises Price Target to $17.7 JP Morgan analyst Craig McDowell has maintained an Overweight rating on Wise Group (NASDAQ: WSE) and raised the price target from $17.3 to $17.7. This adjustment reflects a positive outlook for the company. https://www.openbell.ai/news/SPY:1792165182353 2026-10-16T15:39:42.353Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Expects U.S. Fed To Deliver A 25 BP Rate Hike Each In December And January Vs Prior Forecast Of A Hike In December This Year Barclays has revised its forecast for U.S. Federal Reserve interest rate hikes, now expecting a 25 basis point increase in both December 2023 and January 2024, compared to its previous prediction of a single hike in December. This change reflects Barclays' updated outlook on monetary policy and its implications for the market. https://www.openbell.ai/news/TRV:1792165141107 2026-10-16T15:39:01.107Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Travelers-Companies.jpg?width=250&height=187 Travelers Companies Stock Is Gaining Friday: What's Going On? Travelers Companies Inc. (NYSE: TRV) reported strong third-quarter results, with adjusted earnings of $9.18 per share surpassing the analyst estimate of $7.42, while revenue fell slightly to $12.41 billion, exceeding expectations of $11.38 billion. The company returned $1.8 billion to shareholders through share repurchases and dividends, and its adjusted book value per share increased by 15% to $172.47. Despite a rise in catastrophe losses to $538 million, the combined ratio improved to 86.8%, indicating an underwriting profit. As of Friday, Travelers shares were up 1.01% at $387.76, nearing its 52-week high of $398.69. https://www.openbell.ai/news/RIOT:1792164651592 2026-10-16T15:30:51.592Z daily 0.9 https://cdn.brandfetch.io/RIOT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of AI cloud services companies are trading lower amid persistent concerns over the debt required to sustain the AI infrastructure buildout. Sentiment is also under pressure following a Gartner warning about the outlook for neocloud providers, fueling concerns over the sustainability of spending on AI computing capacity. openbell Financial News https://www.openbell.ai/news/UNH:1792164645467 2026-10-16T15:30:45.467Z daily 0.9 https://cdn.brandfetch.io/UNH/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on UnitedHealth Group, Raises Price Target to $524 JP Morgan analyst Lisa Gill has maintained an Overweight rating on UnitedHealth Group (NYSE: UNH) and increased the price target from $516 to $524. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/APLD:1792164071477 2026-10-16T15:21:11.477Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/The-Applied-Digital-Corporation-Logo-Is-.jpg?width=250&height=187 Why Is Applied Digital Stock Falling Friday? Applied Digital Corp. (NASDAQ: APLD) experienced a 7.21% decline in stock price, trading at $18.92, amid concerns over AI infrastructure financing costs and a broader sell-off in AI data-center stocks. The Nasdaq index fell by 0.68%, while the S&P 500 saw a slight gain of 0.07%. The downturn is linked to rising debt levels and high bond yields, particularly following CoreWeave Inc.'s bond issue, which saw yields peak at 15%. Technical indicators show that APLD is trading significantly below its major moving averages, indicating a bearish trend. https://www.openbell.ai/news/AAPG:1792163607565 2026-10-16T15:13:27.565Z daily 0.9 https://cdn.brandfetch.io/AAPG/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Ascentage Pharma Group with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Ascentage Pharma Group (NASDAQ: AAPG) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/EW:1792163587622 2026-10-16T15:13:07.622Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Irvine--California---7-May-2023-Edwards-.jpg?width=250&height=187 FDA Flags High-Risk Heart Device Recall At Edwards Lifesciences After Patient Death The FDA has issued a high-risk alert regarding a recall of specific lots of Edwards Lifesciences' Commander M delivery systems after reports of balloons bursting during procedures, which resulted in one patient death and a serious injury. The company has advised customers to stop using the affected products and to coordinate returns with company representatives. As a result of the recall, Edwards Lifesciences' stock price fell by 0.86% to $87.34. https://www.openbell.ai/news/SKHY:1792163504141 2026-10-16T15:11:44.141Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: South Korea’s KOSPI Logs Worst Week Since 2008’s Lehman Brothers Collapse The KOSPI index in South Korea experienced a significant decline of 14.46% for the week, marking its worst performance since the Lehman Brothers collapse in October 2008. Notably, SK Hynix Inc. fell 24.3% and Samsung Electronics Co. Ltd. dropped 17.8%, both reflecting their steepest weekly losses since that period. The KOSPI is currently 37.8% below its record close of 9,114.55, despite being up 34.5% in 2026. Additionally, the iShares MSCI South Korea ETF was down over 13% during Friday trading. https://www.openbell.ai/news/WDAY:1792163434182 2026-10-16T15:10:34.182Z daily 0.9 https://cdn.brandfetch.io/WDAY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Workday shares are trading lower after Keybanc downgraded the stock from Overweight to Sector Perform. openbell Financial News https://www.openbell.ai/news/RKLB:1792163257072 2026-10-16T15:07:37.072Z daily 0.9 https://cdn.brandfetch.io/RKLB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rocket Lab shares are trading lower after Citizens lowered its price target on the stock from $130 to $90. openbell Financial News https://www.openbell.ai/news/EWTX:1792163152572 2026-10-16T15:05:52.572Z daily 0.9 https://cdn.brandfetch.io/EWTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Edgewise Therapeutics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Edgewise Therapeutics (NASDAQ: EWTX) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/HUT:1792163094722 2026-10-16T15:04:54.722Z daily 0.9 https://cdn.brandfetch.io/HUT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hut 8 shares are trading lower after Cantor Fitzgerald lowered its price target on the stock from $180 to $151. openbell Financial News https://www.openbell.ai/news/LLY:1792163071799 2026-10-16T15:04:31.799Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Los-Angeles--California---July-7-2025-El.jpg?width=250&height=187 Eli Lilly's GLP-1 Pill Wins Key European Backing for Obesity and Diabetes Eli Lilly and Co's new medication, Foundayo, has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for marketing authorization in Europe, aimed at treating type 2 diabetes and aiding weight management. Foundayo, which contains the active ingredient orforglipron, is indicated for adults with obesity or overweight conditions alongside diet and exercise. Following the announcement, Eli Lilly's stock rose by 1.44% to $1269.60, nearing its 52-week high of $1292.65. https://www.openbell.ai/news/JKHY:1792163013340 2026-10-16T15:03:33.340Z daily 0.9 https://cdn.brandfetch.io/JKHY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jack Henry To Provide Tokenized Deposits Under Expanded Partnership With Google Cloud Through Universal Ledger Jack Henry (NASDAQ: JKHY) has announced an expansion of its partnership with Google Cloud to provide tokenized deposits through the Google Cloud Universal Ledger (GCUL). This collaboration positions Jack Henry as the first core technology provider to integrate with GCUL, enabling banks and credit unions to modernize their deposit offerings and enhance customer relationships. GCUL is a managed distributed ledger service that allows financial institutions to tokenize and transfer assets with real-time settlement capabilities. https://www.openbell.ai/news/RVMD:1792162969433 2026-10-16T15:02:49.433Z daily 0.9 https://cdn.brandfetch.io/RVMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Revolution Medicines with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Revolution Medicines (NASDAQ: RVMD) with an Outperform rating. This marks a positive outlook for the company as it enters a new phase of market analysis. https://www.openbell.ai/news/PSX:1792162945267 2026-10-16T15:02:25.267Z daily 0.9 https://cdn.brandfetch.io/PSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Phillips 66 Raises Quarterly Dividend From $1.27 To $1.33 Per Share Phillips 66 (NYSE: PSX) has announced an increase in its quarterly dividend from $1.27 to $1.33 per share, marking a $0.06 increase. The new dividend will be payable on December 1, 2026, to shareholders on record as of November 17, 2026. https://www.openbell.ai/news/SPY:1792162820453 2026-10-16T15:00:20.453Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Charts-Of-Financial-Instruments-With-Var.jpg?width=250&height=187 9 Of 11 Sectors Rise In Friday Trading As Cyclicals Lead On Friday, nine of the eleven sectors in the market experienced gains, with the Materials sector leading at +1.62%, followed by Energy at +1.14% and Financials at +0.99%. The major averages showed mixed results, with the SPDR S&P 500 ETF Trust (SPY) down 0.06% and the Invesco QQQ Trust down 0.92%, while the Dow Jones Industrial Average ETF rose 0.42%. Notably, the Technology sector lagged, declining by 1.28%, driven by losses in major companies like Oracle and Microsoft. https://www.openbell.ai/news/UCBJF:1792162421609 2026-10-16T14:53:41.609Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Doctor-Working-On-Virtual-Touch-Screen-P.jpg?width=250&height=187 UCB Scores FDA Win With First-Of-Its-Kind Daily Autoinjector for Rare Muscle Disorder UCB SA has received FDA approval for its Zilbrysq autoinjector, the first self-administered, once-daily treatment for generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor antibody-positive. The approval is based on data from three studies, including a Phase 3b study showing a 99.8% complete dose delivery rate. The autoinjector is expected to be commercially available in the first quarter of 2027, complementing UCB's existing gMG portfolio, which includes RYSTIGGO. https://www.openbell.ai/news/CLW:1792162251061 2026-10-16T14:50:51.061Z daily 0.9 https://cdn.brandfetch.io/CLW/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Clearwater Paper, Raises Price Target to $23 RBC Capital analyst Matthew McKellar has maintained an Outperform rating on Clearwater Paper (NYSE: CLW) and raised the price target from $21 to $23. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/CYTK:1792162194933 2026-10-16T14:49:54.933Z daily 0.9 https://cdn.brandfetch.io/CYTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Cytokinetics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Cytokinetics (NASDAQ: CYTK) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/NVA:1792162092554 2026-10-16T14:48:12.554Z daily 0.9 https://cdn.brandfetch.io/NVA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Spruce Point Capital Raises Concern Over Nova Minerals' Purchase Of Antimony Ore In FY26; Says Its Running Out Of Cash Spruce Point Capital has raised concerns regarding Nova Minerals' acquisition of antimony ore scheduled for fiscal year 2026, highlighting potential financial instability as the company is reportedly running out of cash. The situation may impact Nova Minerals' operational capabilities and future growth prospects. Investors should monitor these developments closely, as they could affect the stock performance of NVA. https://www.openbell.ai/news/KARD:1792162070752 2026-10-16T14:47:50.752Z daily 0.9 https://cdn.brandfetch.io/KARD/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Kardigan with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Kardigan (NASDAQ: KARD) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/KRMN:1792162066229 2026-10-16T14:47:46.229Z daily 0.9 https://cdn.brandfetch.io/KRMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Karman Holdings shares are trading higher after Macquarie initiated coverage on the stock with an Outperform rating and announced a $65 price target. openbell Financial News https://www.openbell.ai/news/CAS:1792162059501 2026-10-16T14:47:39.501Z daily 0.9 https://cdn.brandfetch.io/CAS/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Cascades, Raises Price Target to C$21 RBC Capital analyst Matthew McKellar has maintained an Outperform rating on Cascades (TSX: CAS) and increased the price target from C$18 to C$21. This adjustment reflects a positive outlook for the company. https://www.openbell.ai/news/ETHA:1792162010566 2026-10-16T14:46:50.566Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Eth-Coin-With-Blurred-Candlestick-Chart-.jpg?width=250&height=187 Ethereum ETFs See $60 Million Outflows: Why BlackRock’s ETHA Is Facing Selling Pressure U.S. spot Ethereum ETFs experienced $60.22 million in net outflows on Thursday, marking the second consecutive day of withdrawals, with BlackRock's iShares Ethereum Trust ETF (ETHA) leading the decline at $44.39 million. In contrast, Fidelity's Ethereum Fund (FETH) attracted $2.44 million in inflows, highlighting divergent investor behavior. Despite the outflows, total net assets for U.S. spot Ethereum ETFs remain at $15.29 billion, approximately 5.10% of Ethereum's market capitalization. Investors are closely monitoring Ethereum's upcoming fourth-quarter network upgrade as a potential catalyst for renewed interest in the cryptocurrency. https://www.openbell.ai/news/IMNM:1792161980294 2026-10-16T14:46:20.294Z daily 0.9 https://cdn.brandfetch.io/IMNM/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Immunome with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Immunome (NASDAQ: IMNM) with an Outperform rating. This marks a significant endorsement for the company as it seeks to attract investor interest. https://www.openbell.ai/news/CRCL:1792161899813 2026-10-16T14:44:59.813Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/The-Circle-Trade.jpg?width=250&height=187 Circle Eyes 40 New Markets as Stablecoin Demand Booms, AI Payments Gain Traction Circle Internet Group, Inc. (NYSE: CRCL) plans to expand into nearly 40 emerging markets due to rising demand for stablecoins, as stated by CEO Jeremy Allaire. The company's USDC circulation increased by 19% year-over-year to $73.3 billion in Q2 2026, and it holds nearly 25% of the stablecoin market. Circle recently acquired Tazapay for $400 million and secured a $100 million investment from Binance to enhance its global presence. Analysts expect Circle to report earnings of 36 cents per share on November 4, with projected revenue of $780.98 million. https://www.openbell.ai/news/TNGX:1792161874800 2026-10-16T14:44:34.800Z daily 0.9 https://cdn.brandfetch.io/TNGX/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Tango Therapeutics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Tango Therapeutics (NASDAQ: TNGX) with an Outperform rating. This marks a significant endorsement for the company in the market. https://www.openbell.ai/news/CRWV:1792161842401 2026-10-16T14:44:02.401Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Los-Angeles--California---July-7-2025-Co.jpg?width=250&height=187 CoreWeave Has ‘Darwin Moment’ As Credit Markets Price In 60% Default Odds CoreWeave Inc. (NASDAQ: CRWV) is facing significant financial challenges as its shares fell 6.4% to $65.25, marking a potential weekly loss of about 22%. The company's five-year credit default swaps reached a record 1,194.5 basis points, indicating over a 60% chance of default within five years. CoreWeave generated $679 million in operating cash flow in Q2 but spent approximately $6.4 billion on equipment, leading to a net interest expense that more than doubled to $640 million. https://www.openbell.ai/news/IDYA:1792161741953 2026-10-16T14:42:21.953Z daily 0.9 https://cdn.brandfetch.io/IDYA/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On IDEAYA Biosciences with Outperform Rating William Blair analyst Alethia Young has initiated coverage on IDEAYA Biosciences (NASDAQ: IDYA) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/NI:1792161741492 2026-10-16T14:42:21.492Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Kiev--Ukraine---Jan-7--2019-Nisource-Uti.jpg?width=250&height=187 NiSource Lands Major Microsoft Power Deal NiSource Inc. has entered into a 20-year power supply agreement with Microsoft Corp. to support a data center in northwest Indiana, which will add approximately 1,100 megawatts of new power generation capacity. This deal is expected to increase savings for Northern Indiana Public Service Company (NIPSCO) customers from $1.4 billion to $1.75 billion, translating to an estimated $140 annual savings per customer. NiSource plans to provide further financial details during its upcoming earnings call on October 28, where analysts expect earnings per share of 21 cents and revenue of $1.33 billion. https://www.openbell.ai/news/AA:1792161728618 2026-10-16T14:42:08.618Z daily 0.9 https://cdn.brandfetch.io/AA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of aluminum-related companies are trading higher after Alcoa's better-than-expected Q3 adjusted EPS results and comments that inventories leave little room for another market shock. Also, reports suggesting that U.S. Commerce Secretary Lutnick is refusing to give concessions to Mexican aluminum imports may also aid sentiment for the sector. openbell Financial News https://www.openbell.ai/news/SHOP:1792161702326 2026-10-16T14:41:42.326Z daily 0.9 https://cdn.brandfetch.io/SHOP/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Shopify, Raises Price Target to C$200 RBC Capital analyst Paul Treiber has maintained an Outperform rating on Shopify (TSX: SHOP) and increased the price target from C$180 to C$200. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/PVLA:1792161652409 2026-10-16T14:40:52.409Z daily 0.9 https://cdn.brandfetch.io/PVLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Palvella Therapeutics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Palvella Therapeutics (NASDAQ: PVLA) with an Outperform rating. This marks a significant endorsement for the company as it seeks to enhance its market presence. https://www.openbell.ai/news/SHOP:1792161627985 2026-10-16T14:40:27.985Z daily 0.9 https://cdn.brandfetch.io/SHOP/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Shopify, Raises Price Target to $200 RBC Capital analyst Paul Treiber has maintained an 'Outperform' rating on Shopify (NASDAQ: SHOP) and increased the price target from $180 to $200. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/WVE:1792161540570 2026-10-16T14:39:00.570Z daily 0.9 https://cdn.brandfetch.io/WVE/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Wave Life Sciences with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Wave Life Sciences (NASDAQ: WVE) with an Outperform rating. This marks a positive outlook for the company as it enters a new phase of market evaluation. https://www.openbell.ai/news/EIDO:1792161486574 2026-10-16T14:38:06.574Z daily 0.9 https://cdn.brandfetch.io/EIDO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of U.S.-listed Indonesian companies are trading lower after the MSCI announced the launch of a consultation on a proposal to reclassify the MSCI Indonesia Indexes from Emerging Market to Standalone Market status. openbell Financial News https://www.openbell.ai/news/NUE:1792161450176 2026-10-16T14:37:30.176Z daily 0.9 https://cdn.brandfetch.io/NUE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of steelmakers are trading higher as U.S. steel prices reach a four-year high due to import tariffs. Also, reports suggesting that U.S. Commerce Secretary Lutnick is refusing to give concessions to Mexican steel imports may also be bolstering expectations that protectionism will aid pricing power and margin expansion. openbell Financial News https://www.openbell.ai/news/RYTM:1792161393620 2026-10-16T14:36:33.620Z daily 0.9 https://cdn.brandfetch.io/RYTM/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Rhythm Pharmaceuticals with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Rhythm Pharmaceuticals (NASDAQ: RYTM) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/TCXB:1792161300480 2026-10-16T14:35:00.480Z daily 0.9 https://cdn.brandfetch.io/TCXB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO security released for quotation openbell Financial News https://www.openbell.ai/news/FTH:1792161103224 2026-10-16T14:31:43.224Z daily 0.9 https://cdn.brandfetch.io/FTH/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Faeth Therapeutics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Faeth Therapeutics (NASDAQ: FTH) with an Outperform rating. This marks a significant endorsement for the company in the financial markets. https://www.openbell.ai/news/STX:1792161048309 2026-10-16T14:30:48.309Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Seagate-Technology-Logo-And-Sign.jpg?width=250&height=187 Seagate, Western Digital Face Supply Risks as AI Demand Drives Capacity Expansion Seagate Technology Holdings Plc. (NASDAQ: STX) and Western Digital Corp. (NASDAQ: WDC) are experiencing stock declines due to investor concerns over supply growth and financing risks related to AI infrastructure expansion. Both companies have seen their stocks drop approximately 5% recently, despite being up 110% to 150% in 2026. Increased competition, particularly from Toshiba's plans to double HDD manufacturing capacity by 2027, has raised pricing concerns, while Wall Street firms like UBS have lowered price forecasts amid scrutiny of supply-demand conditions. https://www.openbell.ai/news/NBIS:1792161043080 2026-10-16T14:30:43.080Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Nebius-Group.jpg?width=250&height=187 Why Is Nebius Group Stock Falling Friday? Nebius Group N.V. (NASDAQ: NBIS) stock fell nearly 6% on Friday, trading at $177.29, amid concerns over artificial intelligence infrastructure spending following a Gartner warning that over 80% of neocloud providers may cease independent operations by 2030. The broader technology sector is also experiencing selling pressure, with the Nasdaq down 0.83%. Nebius is expected to report a quarterly loss of 79 cents per share, with revenue projected to rise to $904.29 million from $146.10 million, while analysts maintain a Buy consensus rating with an average price target of $272.62. https://www.openbell.ai/news/RCUS:1792161003574 2026-10-16T14:30:03.574Z daily 0.9 https://cdn.brandfetch.io/RCUS/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Arcus Biosciences with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Arcus Biosciences (NYSE: RCUS) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/TSLA:1792160631912 2026-10-16T14:23:51.912Z daily 0.9 https://cdn.brandfetch.io/TSLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Slovakia Approves Tesla Full Self-Driving System Slovakia has approved Tesla's Full Self-Driving system, marking a significant regulatory milestone for the company. This approval may enhance Tesla's competitive edge in the autonomous vehicle market. The stock ticker for Tesla is TSLA. https://www.openbell.ai/news/MBLY:1792160442758 2026-10-16T14:20:42.758Z daily 0.9 https://cdn.brandfetch.io/MBLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Initiates Coverage On Mobileye Global with Buy Rating, Announces Price Target of $11 Citigroup analyst Michael Ward has initiated coverage on Mobileye Global (NASDAQ: MBLY) with a Buy rating. The firm has set a price target of $11 for the stock.